Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Recruiting now

Conditions studied: Thrombocytopenia, Splenectomy

In brief

Evaluation of immune status before and after splenectomy in immune thrombocytopenia patients.

Key facts

Study ID

NCT03998059

Run by

Institute of Hematology & Blood Diseases Hospital, China

People needed

50

Starts

2019-01-23

Expected to finish

2025-07-23

Last updated by the study team

2025-02-24

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aged 18 to 60 years old, male or female;
• Conform to the diagnostic criteria of immune Thrombocytopenia (ITP)
• Needed splenectomy;
• People who are willing to sign the informed consent voluntarily and follow the research program.

You may not qualify if…

• Secondary thrombocytopenic purpura;
• Patients with poor compliance;
• Researchers believe that patients should not participate in the test of any other condition.

Where it is running

• Yunfei Chen — Tianjin, Tianjin Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.